Edwards, Beatrice J <br/><br/>
Pharmacovigilance and reporting oversight in US FDA fast-track process: bisphosphonates and osteonecrosis of the jaw.  [electronic resource] 

 -  The Lancet. Oncology  Dec 2008 
 - 1166-72 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Review 
<br/><br/><label>ISSN: </label>1474-5488 
<br/><br/><label>Standard No.: </label>10.1016/S1470-2045(08)70305-X  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Oral<br/>Adverse Drug Reaction Reporting Systems<br/>Antineoplastic Agents--administration & dosage<br/>Bone Density Conservation Agents--adverse effects<br/>Diphosphonates--administration & dosage<br/>Drug Approval<br/>Female<br/>Humans<br/>Imidazoles--adverse effects<br/>Incidence<br/>Infusions, Intravenous<br/>Jaw--drug effects<br/>Male<br/>Osteonecrosis--chemically induced<br/>Pamidronate<br/>Precipitating Factors<br/>Tooth Extraction<br/>United States--epidemiology<br/>United States Food and Drug Administration<br/>Zoledronic Acid